Italy to inoculate a booster dose five months after receiving the COVID-19 vaccine

The Italian health authorities may provide the booster dose to those immunized against the COVID-19 when five months have passed since they completed the guideline, the Italian Minister of Health, Roberto Speranza, reported on Monday.

SIGHT: There is a high rate of infections in areas where they vote for the extreme right, according to a study

“The booster dose is crucial to better protect ourselves and those around us. (…) It can be received five months after completing the first guideline ”, the minister wrote on social media.

with at least one dose, while 84.63% have received the full regimen.

SIGHT: COVID-19 may reduce pain in cancer patients discovered

However, in recent days the cases are growing, as in the rest of Europe, and the Government is studying how to control the virus, especially with an eye to Christmas.

This Monday, the president of the Friuli Venezia Giulia region and of the Conference of Regions, Massimiliano Fedriga, asked the Executive not to grant the

SIGHT: COVID-19 strongly increases the possibility of fetal death, study warns

In Italy there is currently the limitation of the use of the mask in closed spaces and the obligation to show the health certificate at leisure or work, which attests the vaccination, negativity or having passed the disease.

Fedriga also asked, on behalf of the rest of the regional authorities, that citizens who enter Italy from countries with high infections and low number of vaccinations be controlled. All with the intention that they would once again penalize the economy and would not be understood after the vaccines, said the president of the Conference of Regions.

Italy has accumulated almost 5 million cases of contagion since February 2020 and 133,000 people have died.

• There is a high rate of infections in areas where they vote for the extreme right, according to a study
• COVID-19 may reduce pain in cancer patients discovered
• The long and turbulent history of mandatory vaccination programs
• The EMA evaluates the booster dose of Johnson & Johnson vaccine in people over 18 years of age
• COVID-19 may reduce pain in cancer patients discovered
• “There is always a risk of a new variant”: Europe increases coronavirus sequencing
• Health policies based on science and evidence, by Elmer Huerta
• The scientific race to find people resistant to COVID-19
• How long do immune cells against COVID-19 last after vaccination?
• COVID-19 | Is herd immunity the goal we should pursue with vaccination?
• A fish vendor from Wuhan market is the first known case of COVID-19, study reveals
• COVID-19 | Masks, confinement and hand washing: are there more effective measures than others?
• Immunotherapy with killed bacteria reduces mortality and boosts vaccines against COVID-19
• Pfizer and Moderna vaccines may give false positives for COVID-19
• AstraZeneca Antibody Drug 83% Protects Against COVID-19 for Six Months
• Pfizer and Moderna vaccines may give false positives for COVID-19
• How is the first drug against COVID-19 that China would have ready in December?
• 82% of COVID-19 cases in Peru are detected in unvaccinated people

Follow us on twitter:

!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);

.

Deshawn